Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection

BACKGROUND: Although mammary cancer (MC) is the most common malignant neoplasia in women, the mortality for this cancer has decreased principally because of early detection and the use of neoadjuvant chemotherapy. Of several preparations that cause MC regression, doxorubicin (DOX) is the most active...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfaro, Yunuen, Delgado, Guadalupe, Cárabez, Alfonso, Anguiano, Brenda, Aceves, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673826/
https://www.ncbi.nlm.nih.gov/pubmed/23705792
http://dx.doi.org/10.1186/1476-4598-12-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673826/
https://www.ncbi.nlm.nih.gov/pubmed/23705792
http://dx.doi.org/10.1186/1476-4598-12-45

Ejemplares similares